急性痛风的治疗选择
Treatment Options for Acute Gout.
作者信息
Coburn Brian W, Mikuls Ted R
机构信息
is a staff rheumatologist and research scientist at the VA Nebraska Western-Iowa Health Care System. is a MD-PhD student and Dr. Mikuls is the Umbach Professor of Rheumatology at the University of Nebraska Medical Center, all in Omaha.
出版信息
Fed Pract. 2016 Jan;33(1):35-40.
Abstract
Careful consideration of comorbidities and contraindications are important when determining the appropriate treatment of patients with gout.
摘要
在确定痛风患者的适当治疗方法时，仔细考虑合并症和禁忌症很重要。
相似文献
1
Treatment Options for Acute Gout.急性痛风的治疗选择
Fed Pract. 2016 Jan;33(1):35-40.
2
Prevalence of contraindications and prescription of pharmacologic therapies for gout.痛风的禁忌症和药物治疗处方的流行情况。
Am J Med. 2011 Feb;124(2):155-63. doi: 10.1016/j.amjmed.2010.09.012.
3
A new perspective on the pharmacoeconomics of colchicine.秋水仙碱的药物经济学新视角。
Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Epub 2011 Mar 3.
4
Managing your patient with gout: a review of treatment options.管理痛风患者：治疗选择综述。
Postgrad Med. 2011 May;123(3):56-71. doi: 10.3810/pgm.2011.05.2284.
5
Current and future therapeutic options for the management of gout.痛风管理的当前和未来治疗选择。
Am J Ther. 2010 Jul-Aug;17(4):402-17. doi: 10.1097/MJT.0b013e3181df8ad2.
6
The safety of treatment options available for gout.痛风现有治疗方案的安全性。
Expert Opin Drug Saf. 2017 Apr;16(4):429-436. doi: 10.1080/14740338.2017.1284199. Epub 2017 Jan 30.
7
Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.比较频繁发作与偶发痛风性关节炎患者的患者特征、与痛风相关的医疗资源利用情况和医疗费用。
Rheumatology (Oxford). 2012 Nov;51(11):2004-12. doi: 10.1093/rheumatology/kes183. Epub 2012 Jul 23.
8
[An update on gout: diagnostic approach, treatment and comorbidity].[痛风的最新进展：诊断方法、治疗及合并症]
Dtsch Med Wochenschr. 2016 Aug;141(16):1164-6. doi: 10.1055/s-0042-107455. Epub 2016 Aug 10.
9
Canakinumab in gout.卡那奴单抗治疗痛风。
Expert Opin Biol Ther. 2012 Sep;12(9):1265-75. doi: 10.1517/14712598.2012.705825. Epub 2012 Jul 12.
10
Management of gout in the older adult.老年痛风的管理
Am J Geriatr Pharmacother. 2011 Oct;9(5):271-85. doi: 10.1016/j.amjopharm.2011.07.004. Epub 2011 Aug 17.
引用本文的文献
1
Therapeutic Potential of Adipose Mesenchymal Stem Cells for Synovial Regeneration: from In-Vitro Studies to Clinical Applications.脂肪间充质干细胞用于滑膜再生的治疗潜力：从体外研究到临床应用
Stem Cell Rev Rep. 2025 Jun 10. doi: 10.1007/s12015-025-10909-5.
2
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.一种新型 NLRP3 抑制剂作为抗单钠尿酸盐诱导痛风的治疗药物。
Front Immunol. 2024 Feb 2;14:1307739. doi: 10.3389/fimmu.2023.1307739. eCollection 2023.
3
The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.香港风湿病学会痛风管理共识建议。
Clin Rheumatol. 2023 Aug;42(8):2013-2027. doi: 10.1007/s10067-023-06578-9. Epub 2023 Apr 4.
4
Measuring quality of gout management in residential aged care facilities.衡量老年护理机构痛风管理的质量。
Rheumatol Adv Pract. 2022 Nov 28;6(3):rkac091. doi: 10.1093/rap/rkac091. eCollection 2022.
本文引用的文献
1
Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease.秋水仙碱在包括终末期肾病在内的肾功能损害受试者中药代动力学差异的单剂量开放标签研究。
Clin Drug Investig. 2014 Dec;34(12):845-55. doi: 10.1007/s40261-014-0238-6.
2
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.用于治疗或预防2型糖尿病、代谢综合征和心血管疾病的抗炎药。
Expert Opin Investig Drugs. 2015 Mar;24(3):283-307. doi: 10.1517/13543784.2015.974804. Epub 2014 Oct 25.
3
Non-steroidal anti-inflammatory drugs for acute gout.用于急性痛风的非甾体抗炎药。
Cochrane Database Syst Rev. 2014 Sep 16(9):CD010120. doi: 10.1002/14651858.CD010120.pub2.
4
Imaging modalities for the classification of gout: systematic literature review and meta-analysis.痛风分类的影像学检查方法：系统文献综述与荟萃分析
Ann Rheum Dis. 2015 Oct;74(10):1868-74. doi: 10.1136/annrheumdis-2014-205431. Epub 2014 Jun 10.
5
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.多国循证推荐意见：痛风的诊断与管理——3e 倡议中广泛的风湿病学家专家组对系统文献回顾和专家意见的整合。
Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.
6
Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review.非甾体抗炎药与慢性肾脏病进展：系统评价。
Fam Pract. 2013 Jun;30(3):247-55. doi: 10.1093/fampra/cms086. Epub 2013 Jan 8.
7
Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.首次医疗接触时即开始使用别嘌醇治疗急性痛风发作：一项随机临床试验。
Am J Med. 2012 Nov;125(11):1126-1134.e7. doi: 10.1016/j.amjmed.2012.05.025.
8
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.2012年美国风湿病学会痛风管理指南。第2部分：急性痛风性关节炎的治疗与抗炎预防
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61. doi: 10.1002/acr.21773.
9
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.2012年美国风湿病学会痛风管理指南。第1部分：高尿酸血症的系统性非药物和药物治疗方法。
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772.
10
Are dosing adjustments required for colchicine in the elderly compared with younger patients?与年轻患者相比，老年人需要调整秋水仙碱的剂量吗？
Adv Ther. 2012 Jun;29(6):551-61. doi: 10.1007/s12325-012-0028-6. Epub 2012 Jun 29.
Zotero 插件